Conquering Diseases

Study To Better Understand How The Drug Edaravone For Als Works In Different People.

Description

Seeking men and women with Amyotrophic Lateral Sclerosis (ALS) who have decided with their doctor to start taking the drug Edaravone to slow their symptom progression for a study of what changes happen in the blood and urine after they start taking the drug.

Overview

We are studying changes in the blood and urine called biomarkers in people who take the drug Edaravone for their ALS. Every participant in this trial will be taking the drug Edaravone to slow their ALS symptom progression.

What we're hoping for

We hope to learn how the drug Edaravone affects the blood and urine of different people with Amyotrophic Lateral Sclerosis (ALS). The drug Edaravone has been approved by the FDA to slow ALS symptom progression.

Additional Information

ClinicalTrials.gov Identifier: NCT04259255

 Principal Investigator

Robert H Brown, MD, PhD

UMass Memorial Health Care

 Study Contact

The Office  of Clinical Research

508-856-5200

clinicalresearch@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989